MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹6,507 Cr | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹6,507 Cr |
| Mar2025 | ₹5,664 Cr |
| Mar2024 | ₹2,120 Cr |
| Mar2023 | ₹1,863 Cr |
| Mar2022 | ₹2,623 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,507 Cr | 14.90 | |
| Mar2025 | ₹5,664 Cr | 167.18 | |
| Mar2024 | ₹2,120 Cr | 13.77 | |
| Mar2023 | ₹1,863 Cr | -28.98 | |
| Mar2022 | ₹2,623 Cr | - | |
Compare Total Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹99,863.4 Cr | -0.9% | -5.1% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.9% |
-5.1% |
-5% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses